Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
NCT03216408
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
504
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
Neuronox
DRUG:
Botox
Sponsor
Medy-Tox